Gilead Sciences Inc (NASDAQ:GILD)
| 89.04 Delayed Data As of Dec 02 |  +1.14 / +1.30%Today’s Change | 57.17 Today|||52-Week Range 89.07 | +22.63% Year-to-Date |
Latest GILD News | Press Releases
Today’s Trading
| Previous close | 87.90 |
| Today’s open | 86.70 |
| Day’s range | 86.53 - 89.07 |
| Volume | 390,843 |
| Average volume (3 months) | 7,816,840 |
| Market cap | $111.7B |
Data as of 4:00pm ET, 12/02/2022
Growth & Valuation
| Earnings growth (last year) | +4,962.51% |
| Earnings growth (this year) | -2.68% |
| Earnings growth (next 5 years) | +0.30% |
| Revenue growth (last year) | +11.08% |
| P/E ratio | 33.7 |
| Price/Sales | 3.35 |
| Price/Book | 5.30 |
Competitors
Data as of 4:00pm ET, 12/02/2022
Financials
| Next reporting date | February 7, 2023 |
| EPS forecast (this quarter) | $1.50 |
| Annual revenue (last year) | $27.4B |
| Annual profit (last year) | $6.2B |
| Net profit margin | 22.74% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Foster City, California |
Forecasts
